Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor (in EN)

Journal Article · · Journal of Medicinal Chemistry
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; « less

Not provided.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-06CH11357
OSTI ID:
2581513
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 19 Vol. 67; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
EN

Similar Records

Discovery of BIIB068: A Selective, Potent, Reversible Bruton?s Tyrosine Kinase Inhibitor as an Orall
Journal Article · Wed Jul 01 00:00:00 EDT 2020 · J. Med. Chem. · OSTI ID:1833661
Discovery of BIIB068: A Selective, Potent, Reversible Bruton?s Tyrosine Kinase Inhibitor as an Orall
Journal Article · Wed Jul 01 00:00:00 EDT 2020 · J. Med. Chem. · OSTI ID:1836743
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Journal Article · Fri Jun 01 00:00:00 EDT 2018 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1474162

Related Subjects

Pharmacology & Pharmacy